Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    "Lymphangioma"
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
Condition: Lymphangioma
Intervention: Drug: Sildenafil
2 Completed Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
Condition: Lymphatic Malformations
Intervention: Drug: picibanil
3 Terminated Selenium in the Treatment of Complicated Lymphatic Malformations
Condition: Lymphatic Malformations
Intervention: Drug: Selenium
4 Recruiting Sildenafil for the Treatment of Lymphatic Malformations
Conditions: Lymphatic Malformations;   Lymphatic Diseases
Interventions: Drug: Sildenafil 20 mg tablets;   Other: Placebo tablets (resembling Revatio)
5 Active, not recruiting Airway Vascular Lesions
Conditions: Hemangiomas;   Venous Malformations;   Lymphatic Malformations
Intervention: Other: Protocols for Treatment
6 Recruiting Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   Lymphangiomatosis
Intervention:
7 Completed Diagnosis of Hemangiomas and Vascular Malformations
Conditions: Hemangiomas;   Vascular Malformations;   Venular Malformations;   Venous Malformations;   Lymphatic Malformations;   Arteriovenous Malformations
Intervention:
8 Active, not recruiting Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Conditions: Kaposiform Hemangioendotheliomas;   Tufted Angioma;   Capillary Venous Lymphatic Malformation;   Venous Lymphatic Malformation;   Microcystic Lymphatic Malformation;   Mucocutaneous Lymphangiomatosis and Thrombocytopenia;   Capillary Lymphatic Arterial Venous Malformations;   PTEN Overgrowth Syndrome With Vascular Anomaly;   Lymphangiectasia Syndromes
Intervention: Drug: sirolimus
9 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat
10 Recruiting Registry for Vascular Anomalies Associated With Coagulopathy
Conditions: Multifocal Lymphangioendotheliomatosis With Thrombocytopenia;   Cutaneovisceral Angiomatosis With Thrombocytopenia;   Vascular Anomaly With Thrombocytopenia;   Hemangiomas
Intervention: Other: no intervention

Study has passed its completion date and status has not been verified in more than two years.